OCUPHIRE PHARMA INC. - COMMON STOCK
1.2900
27-九月-24 14:59:54
15 分钟延时
股票
-0.0100
-0.77%
今日范围
1.2502 - 1.3050
ISIN
N/A
来源
NASDAQ
-
Ocuphire Pharma Announces Financial Results for First Quarter 2023 and Provides Corporate Update
15 5月 2023 07:00:01 条件 Nasdaq GlobeNewswire
-
Ocuphire Announces APX3330 and Nyxol® Data Presentations at ASCRS 2023 and Eyecelerator
02 5月 2023 07:30:00 条件 Nasdaq GlobeNewswire
-
Ocuphire Provides Corporate Update and Reiterates Previous Guidance on Clinical Programs
25 4月 2023 07:00:01 条件 Nasdaq GlobeNewswire
-
Ocuphire Appoints Rick Rodgers as Interim Chief Executive Officer
21 4月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
30 3月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
Ocuphire Announces APX3330 and Nyxol® Data Presentations at ARVO 2023 Annual Meeting
23 3月 2023 07:00:01 条件 Nasdaq GlobeNewswire
-
Ocuphire Announces APX3330 Phase 2 Data Presentations at Retina Meetings
16 2月 2023 07:30:01 条件 Nasdaq GlobeNewswire
-
13 2月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
25 1月 2023 15:01:00 条件 Nasdaq GlobeNewswire
-
09 1月 2023 06:00:01 条件 Nasdaq GlobeNewswire
-
06 12月 2022 05:00:00 条件 Nasdaq GlobeNewswire
-
Ocuphire to Present at Five Upcoming Investor/Industry Conferences
21 11月 2022 07:00:01 条件 Nasdaq GlobeNewswire
-
07 11月 2022 15:05:00 条件 Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Financial Results for Third Quarter 2022 and Provides Corporate Update
04 11月 2022 15:30:00 条件 Nasdaq GlobeNewswire
-
02 11月 2022 07:09:57 条件 Nasdaq GlobeNewswire
-
24 10月 2022 07:56:52 条件 Nasdaq GlobeNewswire
-
Ocuphire Pharma to Present at the MicroCap Rodeo Windy City Roundup 2022 Conference
07 10月 2022 06:00:00 条件 Nasdaq GlobeNewswire
-
Ocuphire Pharma Hosting Key Opinion Leader Event on Oral APX3330 for Diabetic Eye Disease
06 10月 2022 08:27:49 条件 Nasdaq GlobeNewswire
-
Ocuphire Expands Medical Advisory Board with Seven New KOLs and Strengthens Leadership Team
29 9月 2022 07:00:01 条件 Nasdaq GlobeNewswire
-
15 9月 2022 06:00:01 条件 Nasdaq GlobeNewswire